UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

British journal of cancer, 2015-04, Vol.112 (8), p.1358-1366

2015

Link zum Volltext

Verfügbarkeit prüfen

Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Annals of oncology, 2017-01, Vol.28 (1), p.184-184

2017

Link zum Volltext

Verfügbarkeit prüfen

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

British journal of cancer, 2014-10, Vol.111 (9), p.1726-1733

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies

The pharmacogenomics journal, 2017-10, Vol.17 (5), p.441-451

2017

Link zum Volltext

Verfügbarkeit prüfen

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy

Cancer chemotherapy and pharmacology, 2015-04, Vol.75 (4), p.763-772

2015

Link zum Volltext

Verfügbarkeit prüfen

Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii187

2018

Link zum Volltext

Verfügbarkeit prüfen

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii150

2018

Link zum Volltext

Verfügbarkeit prüfen

271 Real-world outcomes of patients with advanced endometrial cancer: a retrospective cohort study of US electronic health records

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A84-A85

2021

Link zum Volltext

Verfügbarkeit prüfen

404MO Clinical relevance of MIR27A rs895819 polymorphism and its interaction with DPYD variants for predicting grade 4-5 fluoropyrimidine (FP) toxicity (tox) in the FUSAFE individual patient data meta-analysis (IPD-MA)

Annals of oncology, 2020-09, Vol.31, p.S413-S413

2020

Link zum Volltext

Verfügbarkeit prüfen

FUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

Annals of oncology, 2019-10, Vol.30, p.v214

2019

Link zum Volltext

Verfügbarkeit prüfen

569P - FUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

Annals of oncology, 2019-10, Vol.30, p.v214-v214

2019

Link zum Volltext

Verfügbarkeit prüfen

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

ESMO open, 2020-08, Vol.5 (4), p.e000856, Article e000856

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of tumor heregulin mRNA expression on outcome of patients with advanced/metastatic squamous NSCLC treated with lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with erlotinib

Annals of oncology, 2016-10, Vol.27, p.vi117-vi117

2016

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and Fracture Patterns of Traumatic Phalangeal Fractures

Plastic and reconstructive surgery. Global open, 2022-08, Vol.10 (8), p.e4455-e4455

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Variation in Intraoperative Technique on Outcomes in Lower Extremity Free Flap Reconstruction

Plastic and reconstructive surgery. Global open, 2021-10, Vol.9 (10S), p.90-91

2021

Link zum Volltext

Verfügbarkeit prüfen

Secondary Surgery following Lower Extremity Free Tissue Reconstruction

Plastic and reconstructive surgery. Global open, 2021-10, Vol.9 (10S), p.80-80

2021

Link zum Volltext

Verfügbarkeit prüfen

569PFUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

561PStandard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Spread of Multidrug Resistant Escherichia coli Isolates Among Nursing Home Residents in the Southern Part of the Netherlands

Journal of the American Medical Directors Association, 2013-03, Vol.14 (3), p.199-203

2013

Link zum Volltext

Verfügbarkeit prüfen

452ODPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

444OPHASE IB TRIAL TRIAL OF RG7116, A GLYCOENGINEERED MONOCLONAL ANTIBODY TARGETING HER3, IN COMBINATION WITH CETUXIMAB OR ERLOTINIB IN PATIENTS WITH ADVANCED/METASTATIC TUMORS OF EPITHELIAL CELL ORIGIN EXPRESSING HER3 PROTEIN

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv147-iv147

2014

Link zum Volltext

Verfügbarkeit prüfen

Secondary amputation after lower extremity free-flap reconstruction

Journal of plastic, reconstructive & aesthetic surgery, 2023-08, Vol.83, p.276-281

2023

Link zum Volltext

Verfügbarkeit prüfen

Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling

Heart rhythm, 2022-09, Vol.19 (9), p.1461-1470

2022

Link zum Volltext

Verfügbarkeit prüfen

Microneedling in Abdominal Scarring after DIEP-flap Breast Reconstruction to Improve Scar Quality: A Randomized Controlled Split Scar Trial

Plastic and reconstructive surgery. Global open, 2024-01, Vol.12 (1), p.e5487-e5487

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(27)
Humans
(21)
Female
(15)
Male
(15)
Middle Aged
(12)
Adult
(9)
Oncology
(9)
Aged
(8)
Biological And Medical Sciences
(8)
Treatment Outcome
(7)
Medical Sciences
(6)
Pharmacology & Pharmacy
(6)
Capecitabine
(5)
Patients
(5)
Risk Factors
(5)
Toxicity
(5)
Aged, 80 And Over
(4)
Dihydrouracil Dehydrogenase - Genetics
(4)
Retrospective Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy

Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

271 Real-world outcomes of patients with advanced endometrial cancer: a retrospective cohort study of US electronic health records

404MO Clinical relevance of MIR27A rs895819 polymorphism and its interaction with DPYD variants for predicting grade 4-5 fluoropyrimidine (FP) toxicity (tox) in the FUSAFE individual patient data meta-analysis (IPD-MA)

FUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

569P - FUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

Impact of tumor heregulin mRNA expression on outcome of patients with advanced/metastatic squamous NSCLC treated with lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with erlotinib

Phase Ib Trial Trial of Rg7116, a Glycoengineered Monoclonal Antibody Targeting Her3, in Combination with Cetuximab or Erlotinib in Patients with Advanced/Metastatic Tumors of Epithelial Cell Origin Expressing Her3 Protein

Epidemiology and Fracture Patterns of Traumatic Phalangeal Fractures

The Effect of Variation in Intraoperative Technique on Outcomes in Lower Extremity Free Flap Reconstruction

Secondary Surgery following Lower Extremity Free Tissue Reconstruction

569PFUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity

561PStandard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers

Prevalence and Spread of Multidrug Resistant Escherichia coli Isolates Among Nursing Home Residents in the Southern Part of the Netherlands

452ODPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

444OPHASE IB TRIAL TRIAL OF RG7116, A GLYCOENGINEERED MONOCLONAL ANTIBODY TARGETING HER3, IN COMBINATION WITH CETUXIMAB OR ERLOTINIB IN PATIENTS WITH ADVANCED/METASTATIC TUMORS OF EPITHELIAL CELL ORIGIN EXPRESSING HER3 PROTEIN

Secondary amputation after lower extremity free-flap reconstruction

Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling

Microneedling in Abdominal Scarring after DIEP-flap Breast Reconstruction to Improve Scar Quality: A Randomized Controlled Split Scar Trial

Suchergebnisse filtern